Written Question · S1W-15698 · Session 1
Further to the answer to question S1W-12788 by Susan Deacon on 7 February 2001, when Aricept will be made available throughout the National…
The question
To ask the Scottish Executive, further to the answer to question S1W-12788 by Susan Deacon on 7 February 2001, when Aricept will be made available throughout the National Health Service in Scotland.
The answer
Donepezil (Aricept) has been licensed since 1997 for the treatment of mild to moderate dementia in Alzheimer's disease. The use of this treatment depends on the clinical judgement of the clinician concerned, taking into account advice and evidence about its use. This will include the Health Technology Board for Scotland's Comment of 1 May 2001 on the Final Appraisal from the National Institute for Clinical Excellence on the use of Aricept, rivastigmine (Exelon) and galantamine (Reminyl).
In the Official Report
No contribution in the Official Report cites S1W-15698 by reference.